✦ LIBER ✦

Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells

✍ Scribed by Andrew J. Rech; Robert H. Vonderheide

Book ID: 111399339
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 177 KB
Volume: 1174
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.2009.04939.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accelerating the secondary immune respon

Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis

✍ Kylie M. Quinn; Fenella J. Rich; Lisa M. Goldsack; Geoffrey W. de Lisle; Bryce M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

## Abstract CD4^+^CD25^+^ natural T regulatory cells (Tregs) have been shown to suppress protective immune responses in several different vaccination models. Since the effect of Tregs on vaccination against tuberculosis (Tb) was unknown, we used a murine model to investigate whether natural Tregs s

The augmentation of tumor-specific immun

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells

✍ Yoshio Shimizu; Hiromi Fujiwara; Shigeharu Ueda; Nobutaka Wakamiya; Shiro Kato; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB